Our Para IV database tracks ALL the ongoing Para IV litigations in the US on real time basis. The database has been created over a painstaking 5 years period with a complete history of each Para IV litigation right from the day of the first Para IV filing. The database is not merely a compilation of the legal information, but also includes information from Citizen’s Petition, SEC filings, concall transcripts and sometimes even direct interaction with the companies involved. In other words, it uses the most comprehensive approach to unravel the strategy behind the Para IV litigation by each involved party.

With this comprehensive approach, the database also offers an educated estimate of probable timeline of generic entry along with likely competition for each company.

Expected First Generic Entry For every Para IV litigation, we forecast likely date of first generic entry of a drug in the US market. Although a lot of the launch related information is sealed, we forecast it based on Patent analysis and Regulatory understanding.